Pancreatic cancer classification: Difference between revisions

	Pancreatic cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pancreatic Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pancreatic cancer classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pancreatic cancer classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pancreatic cancer classification
CDC on Pancreatic cancer classification
Pancreatic cancer classification in the news
Blogs on Pancreatic cancer classification
Directions to Hospitals Treating Pancreatic cancer
Risk calculators and risk factors for Pancreatic cancer classification

VisualWikitext

Revision as of 20:27, 15 November 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S [2]

Overview

Pancreatic cancers can be classified based on the production of hormones into exocrine and endocrine cancers. Pancreatic exocrine tumors include different types such as Adenocarcinoma, Acinar cell carcinoma, Adenosquamous carcinoma and Pancreatoblastomas. Pancreatic endocrine tumors include Insulinomas, Glucagonomas, VIPomas, Somatostatinomas and Ppomas.

Classification

Pancreatic cancers can be classified based on the production of hormones into exocrine and endocrine cancers:

Types of Pancreatic Cancers:^[1]


Types of Pancreatic Cancers
Pancreatic Exocrine Cancers
Adenocarcinoma
Acinar cell carcinoma
Adenosquamous carcinoma
Giant cell tumor
Intraductal papillary mucinous neoplasm (IPMN)
Mucinous cystadenocarcinoma
Pancreatoblastoma
Serous cystadenocarcinoma
Solid and pseudopapillary tumours
Pancreatic Endocrine Cancers (Pancreatic Neuroendocrine Tumours)
Gastrinoma
Glucagonoma
Insulinoma
Nonfunctional islet cell tumor
Somatostatinoma
Vasoactive intestinal peptide releasing tumor (VIPoma)

Types of Pancreatic Intraepithelial Neoplasia (PanIN):^[1]


Types of Pancreatic Intraepithelial Neoplasia (PanIN)
PanIN 1 (low grade)
Minimal degree of atypia
Subclassified into PanIN 1A: absence of micropapillary infoldings of the epithelium; and 1B, presence of micropapillary infoldings of the epithelium
PanIN 2 (intermediate grade)
Moderate degree of atypia, including loss of polarity, nuclear crowding, enlarged nuclei, pseudostratification, and hyperchromatism
Mitosis is rarely seen
PanIN 3 (high grade/carcinoma in situ)
Severe atypia, with varying degrees of cribriforming, luminal necrosis, and atypical mitosis
Contained within the basement membrane

Functional Pancreatic Neuroendocrine Tumors and their Characteristics are mentioned in the following table:^[2]


Functional Pancreatic Neuroendocrine Tumors and their Characteristics
Tumor type and syndrome	Location in pancreas	Signs and symptoms	Circulating biomarkers
Insulinoma (Whipple’s triad)	Head, body, tail (evenly distributed)	Hypoglycemia, dizziness, sweating, tachycardia, tremulousness, confusion, seizure	CgA and CgB, insulin inappropriate for blood glucose level, proinsulin, C-peptide
Gastrinoma (Zollinger–Ellison)	Gastrinoma triangle Often extrapancreatic (duodenal); can be found anywhere in gland	Gastric acid hypersecretion, peptic ulcer, diarrhea, esophagitis, epigastric pain	CgA, gastrin, PP (35%)
VIPoma (Verner– Morrison syndrome, WDHA)	Distal pancreas (body and tail) Often spread outside pancreas	Watery diarrhea, hypokalemia, achlorhydria (or acidosis)	CgA, VIP
Glucagonoma	Body and tail of pancreas Often large and spread outside pancreas	Diabetes (hyperglycemia), necrolytic migratory erythema, stomatitis, glossitis, angular cheilitis	CgA, glucagon, glycentin
Somatostatinoma	Pancreatoduodenal groove, ampullary, periampullary	Gallstones, diabetes (hyperglycemia), steatorrhea	CgA, somatostatin
Ppoma	Head of pancreas	None	CgA, PP

TNM classification for pancreatic cancer:^[1] ^[3]


TNM Classification for Pancreatic Cancer:
Primary tumor

TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
Tis	Carcinoma in situ
T1	Tumor limited to the pancreas, ≤2 cm in greatest dimension
T2	Tumor limited to the pancreas, >2 cm in greatest dimension
T3	Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
T4	Tumor involves the celiac axis or the superior mesenteric artery (unresectable primary tumor)
Regional lymph nodes

NX	Regional lymph nodes cannot be assessed
N0	No regional lymph node metastasis
N1	Regional lymph node metastasis
Distant metastases

MX	Distant metastasis cannot be assessed
M0	No distant metastasis
M1	Distant metastasis

Refrences

↑ ^1.0 ^1.1 ^1.2 Bond-Smith G, Banga N, Hammond TM, Imber CJ (2012). "Pancreatic adenocarcinoma". BMJ. 344: e2476. doi:10.1136/bmj.e2476. PMID 22592847.
↑ Ryan DP, Hong TS, Bardeesy N (2014). "Pancreatic adenocarcinoma". N Engl J Med. 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID 25207767.
↑ Seufferlein T, Bachet JB, Van Cutsem E, Rougier P, ESMO Guidelines Working Group (2012). "Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Ann Oncol. 23 Suppl 7: vii33–40. doi:10.1093/annonc/mds224. PMID 22997452.

Template:WH Template:WS

[pmid22592847-1] 1.0 ^1.1 ^1.2 Bond-Smith G, Banga N, Hammond TM, Imber CJ (2012). "Pancreatic adenocarcinoma". BMJ. 344: e2476. doi:10.1136/bmj.e2476. PMID 22592847.

[pmid25207767-2] Ryan DP, Hong TS, Bardeesy N (2014). "Pancreatic adenocarcinoma". N Engl J Med. 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID 25207767.

[pmid22997452-3] Seufferlein T, Bachet JB, Van Cutsem E, Rougier P, ESMO Guidelines Working Group (2012). "Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Ann Oncol. 23 Suppl 7: vii33–40. doi:10.1093/annonc/mds224. PMID 22997452.

[1]

[2]

[3]

@@ Line 16: / Line 16: @@
 |-
 | style="background:#F5F5F5; + " |
-*Adenocarcinoma
+*[[Adenocarcinoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Acinar cell carcinoma
+*[[Acinic cell carcinoma|Acinar cell carcinoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Adenosquamous carcinoma
+*[[Adenosquamous carcinoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Giant cell tumour
+*Giant cell tumor
 |-
 | style="background:#F5F5F5; + " |
-*Intraductal papillary mucinous neoplasm (IPMN)
+*[[Intraductal papillary mucinous neoplasm]] (IPMN)
 |-
 | style="background:#F5F5F5; + " |
-*Mucinous cystadenocarcinoma
+*[[Mucinous cystadenocarcinoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Pancreatoblastoma
+*[[Pancreatoblastoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Serous cystadenocarcinoma
+*Serous [[cystadenocarcinoma]]
 |-
 | style="background:#F5F5F5; + " |
@@ Line 47: / Line 47: @@
 |-
 | style="background:#F5F5F5; + " |
-*Gastrinoma
+*[[Gastrinoma (patient information)|Gastrinoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Glucagonoma
+*[[Glucagonoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Insulinoma
+*[[Insulinoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Nonfunctional islet cell tumour
+*Nonfunctional islet cell tumor
 |-
 | style="background:#F5F5F5; + " |
-*Somatostatinoma
+*[[Neuroendocrine tumors|Somatostatinoma]]
 |-
 | style="background:#F5F5F5; + " |
-*Vasoactive intestinal peptide releasing tumour (VIPoma)
+*[[VIPoma|Vasoactive intestinal peptide releasing tumor (VIPoma)]]
 |-
 |}
@@ Line 75: / Line 75: @@
 |-
 | style="background:#F5F5F5; + " |
-*Minimal degree of atypia
+*Minimal degree of [[atypia]]
 |-
 | style="background:#F5F5F5; + " |
-*Subclassified into PanIN 1A: absence of micropapillary infoldings of the epithelium; and 1B, presence of micropapillary infoldings of the epithelium
+*Subclassified into PanIN 1A: absence of micropapillary infoldings of the [[epithelium]]; and 1B, presence of micropapillary infoldings of the [[epithelium]]
 |-
 |+
@@ Line 85: / Line 85: @@
 |-
 | style="background:#F5F5F5; + " |
-*Moderate degree of atypia, including loss of polarity, nuclear crowding, enlarged nuclei, pseudostratification, and hyperchromatism
+*Moderate degree of [[atypia]], including loss of [[Chemical polarity|polarity]], nuclear crowding, enlarged [[Cell nucleus|nuclei]], pseudostratification, and hyperchromatism
 |-
 | style="background:#F5F5F5; + " |
-*Mitoses are rarely seen
+*[[Mitosis]] is rarely seen
 |-
 |+
@@ Line 95: / Line 95: @@
 |-
 | style="background:#F5F5F5; + " |
-*Severe atypia, with varying degrees of cribriforming, luminal necrosis, and atypical mitoses
+*Severe [[atypia]], with varying degrees of [[Cribriform|cribriforming]], [[Lumen|luminal]] [[necrosis]], and atypical [[mitosis]]
 |-
 | style="background:#F5F5F5; + " |
-*Contained within the basement membrane
+*Contained within the [[basement membrane]]
 |-
 |}
@@ Line 117: / Line 117: @@
 *Head, body, tail (evenly distributed)
 | style="background:#F5F5F5; + " |
-*Hypoglycemia, dizziness, sweating, tachycardia, tremulousness, confusion, seizure
+*[[Hypoglycemia]], [[dizziness]], [[Perspiration|sweating]], [[tachycardia]], tremulousness, [[confusion]], [[seizure]]
 | style="background:#F5F5F5; + " |
-*CgA and CgB, insulin inappropriate for blood glucose level, proinsulin, C-peptide
+*CgA and CgB, [[insulin]] inappropriate for [[Blood sugar|blood glucose]] level, [[proinsulin]], [[C-peptide]]
 |-
 | style="background:#DCDCDC; + " | '''Gastrinoma (Zollinger–Ellison)'''
 | style="background:#F5F5F5; + " |
-*Gastrinoma triangle Often extrapancreatic (duodenal); can be found anywhere in gland
+*[[Gastrinoma (patient information)|Gastrinoma]] triangle Often extrapancreatic ([[Duodenum|duodenal]]); can be found anywhere in [[gland]]
 | style="background:#F5F5F5; + " |
-*Gastric acid hypersecretion, peptic ulcer, diarrhea, esophagitis, epigastric pain
+*[[Gastric acid]] hypersecretion, [[peptic ulcer]], [[diarrhea]], [[esophagitis]], [[epigastric]] [[pain]]
 | style="background:#F5F5F5; + " |
-*CgA, gastrin, PP (35%)
+*CgA, [[gastrin]], PP (35%)
 |-
 | style="background:#DCDCDC; + " | '''VIPoma (Verner– Morrison syndrome, WDHA)'''
 | style="background:#F5F5F5; + " |
-*Distal pancreas (body and tail) Often spread outside pancreas
+*Distal [[pancreas]] (body and tail) Often spread outside [[pancreas]]
 | style="background:#F5F5F5; + " |
-*Watery diarrhea, hypokalemia, achlorhydria (or acidosis)
+*[[Diarrhea|Watery diarrhea]], [[hypokalemia]], [[achlorhydria]] (or acidosis)
 | style="background:#F5F5F5; + " |
-*CgA, VIP
+*CgA, [[Vasoactive intestinal peptide|VIP]]
 |-
 | style="background:#DCDCDC; + " | '''Glucagonoma'''
 | style="background:#F5F5F5; + " |
-*Body and tail of pancreas Often large and spread outside pancreas
+*Body and tail of [[pancreas]] Often large and spread outside [[pancreas]]
 | style="background:#F5F5F5; + " |
-*Diabetes (hyperglycemia), necrolytic migratory erythema, stomatitis, glossitis, angular cheilitis
+*[[Diabetes]] ([[hyperglycemia]]), [[necrolytic migratory erythema]], [[stomatitis]], [[glossitis]], [[angular cheilitis]]
 | style="background:#F5F5F5; + " |
-*CgA, glucagon, glycentin
+*CgA, [[glucagon]], glycentin
 |-
 | style="background:#DCDCDC; + " | '''Somatostatinoma'''
+| style="background:#F5F5F5; + " |
+*Pancreatoduodenal groove, [[Ampulla of Vater|ampullary]], periampullary
 | style="background:#F5F5F5; + " |
-*Pancreatoduodenal groove, ampullary, periampullary
+*[[Gallstone disease|Gallstones]], [[diabetes]] (hyperglycemia), [[steatorrhea]]
-| style="background:#F5F5F5; + " |
-*Gallstones, diabetes (hyperglycemia), steatorrhea
 | style="background:#F5F5F5; + " |
-*CgA, somatostatin
+*CgA, [[somatostatin]]
 |-
 | style="background:#DCDCDC; + " | '''Ppoma'''
 | style="background:#F5F5F5; + " |
-*Head of pancreas
+*Head of [[pancreas]]
 | style="background:#F5F5F5; + " |
 *None
@@ Line 175: / Line 175: @@
 |-
 | style="background:#DCDCDC; + " | TX
-| style="background:#F5F5F5; + " | Primary tumor cannot be assessed
+| style="background:#F5F5F5; + " | Primary [[tumor]] cannot be assessed
 |-
 | style="background:#DCDCDC; + " | T0
-| style="background:#F5F5F5; + " | No evidence of primary tumor
+| style="background:#F5F5F5; + " | No evidence of primary [[tumor]]
 |-
 | style="background:#DCDCDC; + " | Tis
-| style="background:#F5F5F5; + " | Carcinoma ''in situ''
+| style="background:#F5F5F5; + " | [[Carcinoma]] ''in situ''
 |-
 | style="background:#DCDCDC; + " | T1
-| style="background:#F5F5F5; + " | Tumor limited to the pancreas, ≤2 cm in greatest dimension
+| style="background:#F5F5F5; + " | [[Tumor]] limited to the [[pancreas]], ≤2 cm in greatest dimension
 |-
 | style="background:#DCDCDC; + " | T2
-| style="background:#F5F5F5; + " | Tumor limited to the pancreas, >2 cm in greatest dimension
+| style="background:#F5F5F5; + " | [[Tumor]] limited to the [[pancreas]], >2 cm in greatest dimension
 |-
 | style="background:#DCDCDC; + " | T3
-| style="background:#F5F5F5; + " | Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
+| style="background:#F5F5F5; + " | [[Tumor]] extends beyond the [[pancreas]] but without involvement of the [[Celiac artery|celiac]] axis or the [[superior mesenteric artery]]
 |-
 | style="background:#DCDCDC; + " | T4
-| style="background:#F5F5F5; + " | Tumor involves the celiac axis or the superior mesenteric artery (unresectable primary tumor)
+| style="background:#F5F5F5; + " | Tumor involves the [[Celiac artery|celiac]] axis or the [[superior mesenteric artery]] (unresectable primary [[tumor]])
 |+
 | colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Regional lymph nodes'''
@@ Line 201: / Line 201: @@
 |-
 | style="background:#DCDCDC; + " | NX
-| style="background:#F5F5F5; + " | Regional lymph nodes cannot be assessed
+| style="background:#F5F5F5; + " | Regional [[Lymph node|lymph nodes]] cannot be assessed
 |-
 | style="background:#DCDCDC; + " | N0
-| style="background:#F5F5F5; + " | No regional lymph node metastasis
+| style="background:#F5F5F5; + " | No regional [[lymph node]] metastasis
 |-
 | style="background:#DCDCDC; + " | N1
-| style="background:#F5F5F5; + " | Regional lymph node metastasis
+| style="background:#F5F5F5; + " | Regional [[lymph node]] metastasis
 |+
 | colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Distant metastases'''
@@ Line 215: / Line 215: @@
 |-
 | style="background:#DCDCDC; + " | MX
-| style="background:#F5F5F5; + " | Distant metastasis cannot be assessed
+| style="background:#F5F5F5; + " | Distant [[metastasis]] cannot be assessed
 |-
 | style="background:#DCDCDC; + " | M0
-| style="background:#F5F5F5; + " | No distant metastasis
+| style="background:#F5F5F5; + " | No distant [[metastasis]]
 |-
 | style="background:#DCDCDC; + " | M1
-| style="background:#F5F5F5; + " | Distant metastasis
+| style="background:#F5F5F5; + " | Distant [[metastasis]]
 |-
 |}

Pancreatic cancer classification: Difference between revisions

Revision as of 20:27, 15 November 2017

Overview

Classification

Refrences

Navigation menu